Diagnosing an intracranial aneurysm requires specialized imaging techniques that can detect weak spots in brain blood vessels before they cause serious problems. Most brain aneurysms are discovered unexpectedly during tests for other conditions, since they often don’t cause symptoms until they grow large or rupture.

Introduction: Who Should Undergo Diagnostics

Understanding when to seek diagnostic testing for an intracranial aneurysm can be lifesaving. Most people with brain aneurysms don’t know they have one because small aneurysms typically don’t produce any warning signs. They’re often discovered by chance when someone undergoes brain imaging for an entirely different reason, such as persistent headaches, migraines, or other neurological concerns.^[1]

However, certain symptoms should prompt immediate medical attention and diagnostic evaluation. If you experience a sudden, extremely severe headache that feels different from any headache you’ve had before—sometimes described as “the worst headache of your life” or a thunderclap headache—you need emergency care right away. This type of headache can indicate that an aneurysm has ruptured and is bleeding into the brain, which is a life-threatening emergency.^[3]

People with certain risk factors may benefit from screening even without symptoms. If you have two or more first-degree relatives (parents, siblings, or children) who have had brain aneurysms, doctors become more concerned that other family members might also harbor these blood vessel abnormalities. In such cases, your healthcare provider might recommend screening tests to check for unruptured aneurysms.^[4]

Additionally, individuals with specific medical conditions are at higher risk and may need monitoring. These conditions include polycystic kidney disease, certain connective tissue disorders like Ehlers-Danlos syndrome, and arteriovenous malformations (abnormal tangles of blood vessels). People with a history of head trauma or infections affecting blood vessels may also warrant diagnostic evaluation.^[4]

Larger unruptured aneurysms may cause symptoms by pressing on nearby brain tissue or nerves. These symptoms can include pain above or behind the eye, numbness or weakness on one side of the face, changes in vision such as double vision, problems with balance or dizziness, difficulty with concentration and speech, or a dilated pupil in one eye. If you experience any of these symptoms persistently, it’s advisable to consult your doctor about whether diagnostic imaging might be appropriate.^[6]

Classic Diagnostic Methods

Diagnosing an intracranial aneurysm involves several sophisticated imaging techniques that allow doctors to visualize the blood vessels in your brain without surgery. The choice of which test to use depends on your symptoms, your medical history, and whether doctors suspect a ruptured or unruptured aneurysm.

CT Scan and CT Angiography

A computed tomography (CT) scan is typically the first test performed when doctors suspect a ruptured brain aneurysm. This specialized X-ray examination takes multiple images of your brain from different angles and uses computer processing to create detailed cross-sectional pictures, like slices through your brain. The test is quick, usually taking only a few minutes, which makes it ideal for emergency situations.^[8]

When someone arrives at the emergency room with symptoms suggesting a ruptured aneurysm, the CT scan can quickly reveal whether there’s bleeding in or around the brain. This is crucial because timing matters enormously in treating a bleeding aneurysm—the longer blood continues to leak, the more damage occurs and the higher the risk of death or permanent disability.^[3]

A more advanced version called CT angiography (CTA) provides even more detailed information about the blood vessels themselves. During this test, a special dye (contrast material) is injected into a vein in your arm. This dye travels through your bloodstream and makes your brain’s arteries show up more clearly on the CT images. CT angiography can reveal the exact location, size, and shape of an aneurysm, helping doctors plan the best treatment approach.^[5]

Magnetic Resonance Imaging (MRI) and MR Angiography

Magnetic resonance imaging uses powerful magnets and radio waves instead of X-rays to create detailed images of your brain. Unlike CT scans, MRI doesn’t involve radiation exposure, though the examination takes longer—sometimes 30 to 60 minutes. You’ll need to lie still inside a tube-like machine during the scan, which can feel confining for some people.^[8]

MR angiography (MRA) is a specialized type of MRI that focuses specifically on blood vessels. It can produce three-dimensional images of the arteries in your brain, showing the size, shape, and location of an aneurysm with remarkable clarity. MRA is particularly useful for detecting unruptured aneurysms and for monitoring known aneurysms over time to see if they’re growing or changing.^[8]

Both MRI and MRA can be performed with or without contrast dye, though the contrast often provides clearer images of blood vessels. These tests are excellent for follow-up examinations because they don’t involve radiation, meaning they can be repeated as often as necessary without adding health risks from radiation exposure.

Cerebral Angiography

Cerebral angiography, also called conventional angiography or digital subtraction angiography, is considered the most detailed and accurate test for diagnosing brain aneurysms. However, it’s more invasive than CT or MRI scans. During this procedure, a doctor inserts a thin, flexible tube called a catheter into an artery, usually in your groin or wrist. Using X-ray guidance, the catheter is carefully threaded through your blood vessels until it reaches the arteries in your brain.^[8]

Once the catheter is in position, a special contrast dye is injected directly into the brain’s arteries. As the dye flows through your blood vessels, a series of X-ray images captures detailed pictures of the arteries from multiple angles. This creates a complete map of your brain’s blood vessel system, revealing not just the presence of an aneurysm but also its precise size, shape, relationship to surrounding vessels, and whether it has multiple lobes or a narrow neck connecting it to the parent artery.^[5]

Because cerebral angiography is more invasive than other imaging tests, it carries slightly higher risks, including a small chance of stroke, bleeding, or damage to blood vessels. However, it provides information that sometimes cannot be obtained any other way, particularly when doctors are planning surgical or endovascular treatment. The test is often performed just before treatment so that if an aneurysm is found, it can be treated during the same procedure.

Lumbar Puncture (Spinal Tap)

A lumbar puncture, commonly called a spinal tap, may be performed when doctors suspect a ruptured aneurysm but a CT scan doesn’t show clear evidence of bleeding. This can happen if the bleeding is very small or if too much time has passed since the rupture occurred and the blood has already been partially absorbed.^[8]

During this procedure, a doctor inserts a thin needle into your lower back to collect a small sample of cerebrospinal fluid (CSF)—the clear fluid that surrounds and cushions your brain and spinal cord. The needle is inserted below the level where your spinal cord ends, so there’s no risk of damaging the cord itself. If an aneurysm has ruptured, red blood cells will be present in the cerebrospinal fluid, confirming that bleeding has occurred in the brain.^[5]

The procedure typically takes about 30 minutes and is performed while you lie on your side with your knees drawn up toward your chest. You’ll receive local anesthesia to numb the area, though you may feel some pressure or a brief sharp sensation when the needle is inserted. After the procedure, you may need to lie flat for a few hours to reduce the risk of developing a headache.

How Tests Distinguish Aneurysms from Other Conditions

Diagnostic imaging helps doctors differentiate brain aneurysms from other conditions that might cause similar symptoms. For example, severe headaches can result from migraines, tumors, infections, or other blood vessel problems. CT and MRI scans can reveal whether a mass is present, whether there’s swelling or infection in the brain, or whether blood vessels appear abnormal in ways other than aneurysms.^[1]

When imaging reveals an aneurysm, doctors also assess characteristics that help predict its risk of rupture. They measure the aneurysm’s size—small aneurysms (less than 3 millimeters) are less likely to rupture than larger ones. They evaluate its shape—irregular or multilobed aneurysms carry higher risk than smooth, round ones. They note its location—aneurysms in certain areas of the brain, particularly in the back part of the brain called the posterior circulation, are more prone to rupture.^[4]

Diagnostics for Clinical Trial Qualification

When patients with brain aneurysms are considered for enrollment in clinical trials, they must undergo specific diagnostic procedures to determine their eligibility. Clinical trials test new treatments or techniques for managing aneurysms, and precise diagnostic information ensures that only appropriate candidates participate and that results can be accurately interpreted.

Standard Imaging Requirements

Clinical trials typically require high-quality imaging studies performed according to standardized protocols. This usually means obtaining either CT angiography or MR angiography within a specific timeframe before enrollment—often within days or weeks, depending on the trial. These images must be of sufficient quality to accurately measure the aneurysm’s dimensions and assess its characteristics.^[10]

For trials studying ruptured aneurysms, participants must have diagnostic confirmation of subarachnoid hemorrhage—the type of bleeding that occurs when an aneurysm ruptures. This confirmation typically comes from CT scan findings showing blood in the space around the brain, or from lumbar puncture showing red blood cells in the cerebrospinal fluid. The diagnostic tests must clearly link the bleeding to a specific aneurysm that can be visualized on imaging.^[2]

Neurological Assessment

Beyond imaging, clinical trials often use standardized scales to assess patients’ neurological condition. For ruptured aneurysms, researchers commonly use the Hunt and Hess grading scale, which classifies patients based on the severity of their symptoms. Grade 1 represents minimal symptoms (perhaps just a mild headache or slight neck stiffness), while Grade 5 represents the most severe condition (coma with abnormal body positioning). This grading helps ensure that trial participants are similar enough to produce meaningful results and that treatments are tested on appropriate patient populations.^[9]

Patients being evaluated for trials may undergo additional neurological examinations to document their cognitive function, muscle strength, sensation, speech, vision, and other neurological abilities. These baseline assessments allow researchers to measure whether a new treatment improves outcomes compared to standard care.

Laboratory Tests

Blood tests form another component of diagnostic workup for clinical trial participation. These typically include complete blood counts to assess red blood cells, white blood cells, and platelets; tests of kidney and liver function; and measurements of substances in the blood that might affect aneurysm treatment or recovery. For example, blood sodium levels are checked because abnormalities can occur after aneurysm rupture and affect the brain’s function.^[2]

Some trials may require genetic testing if they’re studying aneurysms that run in families or investigating whether certain genetic factors influence treatment response. Other specialized blood tests might measure inflammatory markers or other substances that researchers believe could be related to aneurysm formation, growth, or rupture.

Exclusion Criteria Based on Diagnostics

Diagnostic findings can also disqualify patients from certain clinical trials. For instance, trials testing new endovascular techniques might exclude patients whose aneurysm anatomy makes the procedure technically impossible. Imaging might reveal that an aneurysm has too wide a neck, is located in an inaccessible position, or has a shape that won’t accommodate the devices being studied.^[10]

Other diagnostic findings that commonly exclude patients from trials include evidence of previous brain surgery or aneurysm treatment, presence of multiple aneurysms when the trial focuses on single aneurysms, or detection of other brain conditions that could interfere with study results or put the patient at excessive risk.

Serial Imaging in Trials

Once enrolled in a clinical trial, participants typically undergo repeated diagnostic imaging at predetermined intervals. These follow-up scans assess whether an aneurysm is stable, growing, or successfully treated. For unruptured aneurysms being monitored without immediate treatment, serial imaging might occur every six months to yearly. For treated aneurysms, imaging often happens shortly after treatment, then at intervals of months to years to ensure the aneurysm remains sealed and no complications have developed.^[11]

Different trials may use different imaging modalities for follow-up. Some prefer noninvasive techniques like CT angiography or MR angiography to minimize risk to participants, while others may require periodic conventional angiography to obtain the most detailed possible information about treatment durability. The imaging protocol is carefully designed as part of the trial’s scientific plan to answer specific research questions about the treatment being studied.